Es M, Shapiro CL, Motiwala T, Jacob ST: Estrogen-mediated suppression from the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and part in tamoxifen sensitivity. Mol Endocrinol 2009, 23(two):176?87. Mori Y, Yin J, Sato F, Sterian A, Simms LA, Selaru FM, Schulmann K, Xu Y, Olaru A, Wang S, Deacu E, Abraham JM, Young J, Leggett BA, Meltzer SJ: Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res 2004, 64(7):2434?438. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM: Molecular evaluation of a human interferon-inducible gene loved ones. Eur J Biochem 1991, 199:417?23. Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, Perret C, Romagnolo B: Identification of the IFITM family as a brand new molecular marker in human colorectal tumors. Cancer Res 2006, 66(four):1949?955.Virag et al. BMC Genomics 2013, 14:480 http://www.biomedcentral.com/1471-2164/14/Page 16 of37. Ghaleb AM, Aggarwal G, Bialkowska AB, Nandan MO, Yang VW: Notch inhibits expression in the Kr pel-like aspect 4 tumor suppressor within the intestinal epithelium. Mol Cancer Res 2008, 6:1920?927. 38. Strzelczyk B, Szulc A, Rzepko R, Kitowska A, Skokowski J, Szutowicz A, Pawelczyk T: Identification of high-risk stage II colorectal PS210 MedChemExpress tumors by combined analysis on the NDRG1 gene expression plus the depth of tumor invasion. Ann Surg Oncol 2009, 16(5):1287?294. 39. Guo JY, Yamada A, Kajino T, Wu JQ, Tang W, Freel CD, Feng J, Chau BN, Wang MZ, Margolis SS, Yoo HY, Wang XF, Dunphy WG, Irusta PM, Hardwick JM, Kornbluth S: Aven-dependent activation of ATM following DNA damage. Curr Biol 2008, 18(13):933?42. 40. Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier R: Cellsurface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ 2011. doi:ten.1038/cdd.2011.123. 41. Ao JE, Kuang LH, Zhou Y, Zhao R, Yang CM: Hypoxia-inducible aspect 1 regulated ARC expression mediated hypoxia induced inactivation on the intrinsic death pathway in p53 deficient human colon cancer cells. Biochem Biophys Res Commun 2012, 420(4):913?17. 42. Wang C, Li N, Liu X, Zheng Y, Cao X: A novel endogenous human CaMKII inhibitory protein suppresses tumor development by inducing cell cycle arrest by way of p27 stabilization. J Biol Chem 2008, 283(17):11565?1574. 43. Huang L, Li MX, Wang L, Li BK, Chen GH, He LR, Xu L, Yuan YF: Prognostic worth of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that may be independent of gene methylation. Tumour Biol 2011, 32(1):233?40. 44. Eto N, Miyagishi M, Inagi R, Fujita T, Nangaku M: Mitogen-activated protein three kinase 6 mediates angiogenic and tumorigenic effects by means of vascular endothelial development aspect expression. Am J Pathol 2009, 174(four):1553?563. 45. Cara A, Rabik M, Dolan E: Molecular mechanisms of resistance and toxicity linked to platinating L-Cysteine Epigenetic Reader Domain agents. Cancer Treat Rev 2007, 33(1):9?three. 46. Valdimarsdottir G, Goumans MJ, Rosendahl A, Brugman M, Itoh S, Lebrin F, Sideras P, ten Dijke P: Stimulation of Id1 expression by bone morphogenetic protein is adequate and essential for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002, 106(17):2263?270. 47. Fujisawa T, Sugiyama M, Tomimoto A, Wada K, Endo H, Takahashi H, Yoneda K, Yoneda M, Inamori M, Saito S, Terauchi Y, Kadowaki T, Tsuchiya N, Nakagama H, Nakajima.
